智通财经6月17日电，市场早盘窄幅震荡，三大指数小幅下跌。沪深两市半日成交额7715亿，较上个交 易日缩量166亿。盘面上热点快速轮动，个股跌多涨少，全市场超3000只个股下跌。从板块来看，脑机 接口概念股集体大涨，爱朋医疗等涨停。固态电池概念股震荡走强，赢合科技等涨停。稳定币概念股反 复活跃，恒宝股份再度涨停。下跌方面，创新药概念股冲高回落，科兴制药跌超10%。板块方面，脑机 接口、固态电池、AI眼镜、移动支付等板块涨幅居前，影视、创新药、IP经济、军工等板块跌幅居前。 截至收盘，沪指跌0.19%，深成指跌0.00%，创业板指跌0.14%。 午评：沪指半日跌0.19% 脑机接口概念股集体大涨 ...

Market Overview - The three major A-share indices experienced collective adjustments, with the Shanghai Composite Index down by 0.19%, the Shenzhen Component Index flat, and the ChiNext Index down by 0.14% [1] - The total market turnover for the half-day session was 790.2 billion yuan, a decrease of 15.3 billion yuan compared to the previous day [1] - Over 3,000 stocks in the market were in the red [1] Sector Performance - The brain-computer interface, oil and gas, digital currency, and solid-state battery sectors saw the highest gains [2] - The brain-computer interface concept led the gains, with stocks like Aipeng Medical, Nanjing Panda, Innovation Medical, and Rongtai Health hitting the daily limit [2] - The digital currency sector remained active, with stocks such as Chuangshi Technology and Hengbao shares also hitting the daily limit, while Lakala and Sifang Jingchuang rose over 10% [2] - The solid-state battery sector also performed well, with Yinghe Technology and Keli Yuan reaching the daily limit [2] - The weight loss drug sector led the declines, with Kexing Pharmaceutical dropping over 10% [2] - The IP economy concept stocks collectively adjusted, with several stocks like Hars and Bai Xinglong falling over 5% [2] Notable Stocks and Trends - The top gainers included companies like Xiexin Energy Technology and Zhun Oil, which achieved three consecutive limit-ups [4] - Companies such as Beida Pharmaceutical and Hengbao shares recorded two consecutive limit-ups [5] - The e-commerce sector had nine stocks hitting the daily limit, with Shandong Molong and Zhujiang Piano being notable representatives [6] - The robotics concept saw seven stocks hitting the daily limit, with Gaole shares and Rongtai Health being key players [7] - The Huawei concept also had six stocks hitting the daily limit, including Xiexin Energy Technology and Hengbao shares [8] Innovation Drug Sector - The National Medical Products Administration plans to clarify the category of drugs that will be included in the 30-day review and approval channel for clinical trials of innovative drugs, aiming to support the development of innovative drugs based on clinical value [9] Digital Currency Sector - Circle's stock in the US saw a significant increase, rising nearly 21% and reaching a historical high, with a cumulative increase of over 420% since its listing [10] Brain-Computer Interface Sector - The first brain-computer interface outpatient clinic in Central China has been established, providing technical evaluation and treatment consultation for patients, which may be included in clinical trial queues for cutting-edge treatments [11] - The brain-computer interface industry is expected to grow rapidly, with McKinsey predicting a market size of $40 billion in the medical field by 2030 and potentially exceeding $145 billion by 2040 [12]

Market Overview - The A-share market experienced a slight upward trend with the Shanghai Composite Index rising by 0.06%, the Shenzhen Component Index increasing by 0.26%, and the ChiNext Index up by 0.09% [2] - The brain-computer interface (BCI) concept stocks surged, positively impacting sectors such as biotechnology, pharmaceuticals, and vaccines, while sectors like oil and gas extraction and cultural media faced adjustments [2] Brain-Computer Interface Stocks - BCI concept stocks saw significant gains, with Aipeng Medical (300753) hitting the daily limit of a 20% increase, and Beilu Pharmaceutical (300016) also reaching the 20% limit [5] - Other notable performers included Peking University Pharmaceutical (000788) and Innovation Medical (002173), both achieving daily limits, while Fudan Fuhua (600624), Lepu Medical (300003), and Guanhao Biological (300238) also experienced gains [5] - In the Hong Kong market, Nanjing Panda Electronics (600775) surged over 56%, and Microneuroscience rose over 45% [6] U.S. Market Influence - U.S. stock Brain Rejuvenation saw a dramatic increase of 283%, with a year-to-date rise exceeding 46053%, following FDA approval for its next-generation neuro-regulation chip and a partnership with the Mayo Clinic for Parkinson's disease research [7] Oil and Gas Sector - The oil and gas extraction sector displayed mixed performance, with Junyou Co. (002207) achieving a three-day consecutive rise, while companies like Potential Hengxin (300191) and Nanjing Port (002040) saw declines exceeding 5% [8][9]

消息上，据央视新闻，近日，中国科学院脑科学与智能技术卓越创新中心联合复旦大学附属华山医院， 与相关企业合作，成功开展了我国首例侵入式脑机接口的前瞻性临床试验。该成果标志着我国在侵入式 脑机接口技术上成为全球第二个进入临床试验阶段的国家。 据悉，受试者是一位因高压电事故导致四肢截肢的男性。自2025年3月植入该脑机接口设备以来，系统 运行稳定，仅用2—3周的训练，他便实现了下象棋、玩赛车游戏等功能，达到了跟普通人控制电脑触摸 板相近的水平。未来，这一系统将有望为脊髓损伤、截肢等患者群体，通过运动功能替代技术实现生存 质量改善。 6月17日，脑机接口概念盘中持续活跃，截至发稿，倍益康30%涨停，爱朋医疗20%涨停，创新医疗、 南京熊猫涨停，三博脑科、诚益通、狄耐克等集体大涨。同时，港股脑机接口概念股走强，南京熊猫电 子股份涨超40%，脑洞科技、微创脑科学涨超25%。 我国成功开展了我国首例侵入式脑机接口的前瞻性临床试验，该成果标志着我国在侵入式脑机接口技术 上成为全球第二个进入临床试验阶段的国家。 | 代码 | 名称 | 涨幅号 | 现价 | | --- | --- | --- | --- | | 870199 ...

撰文丨王聪 编辑丨王多鱼 排版丨水成文 想象一下，给胚胎中的大脑植入电子设备，让它随着大脑一起生长、折叠，全程无干扰地监测脑细胞的"一举一 动"……这听起来像科幻小说？哈佛大学的科学家做到了，他们创造出了神奇的"半机械蝌蚪"。 人类的大脑，是整个宇宙中最复杂的结构 （之一） ，它是如何从一个简单的胚胎细胞层一步步发育而来 的？尤其是早期胚胎阶段，大脑形态发生剧烈变化，就像一张平整的纸被精巧地折叠、塑造成一个三维立 体器官。这个过程中神经活动如何萌芽、同步、演化？一直是科学界的巨大谜团。 2025 年 6 月 11 日，哈佛大学 刘嘉 团队在国际顶尖学术期刊 Nature 上发表了题为： Brain implantation of soft bioelectronics via embryonic development 的研究论文。 该研究开发了一种超柔性、超薄、可拉伸的 脑机接口 设备，可利用 胚胎自然发育过程将该设备植入大 脑，能够无缝融合到 大脑发育过程中，对整个大脑的发育过程进行 无创、稳定、持续、高时空分辨率 （毫秒级精度、精确到单个神经元） 的神经电活动记录，而且不会对大脑发育和行为产生影响。 为 ...

【导读】脑机接口概念股大涨，南京熊猫电子股份一度大涨超56% 中国基金报记者 李智 一起来看下 最新 的市场情况及资讯。 6月17日 早盘 ，A股三大指数震荡 拉升。 截至发稿，沪指 涨 0.0 6 %，深成指 涨 0.2 6 %，创业板指 涨 0. 09 %。 | 上证指数 | | 深证成指 | 北证50 | | | --- | --- | --- | --- | --- | | 3390.85 | | 10189.82 | 1412.05 | | | +2.12 | +0.06% | +26.28 +0.26% | +3.90 | +0.28% | | 科创50 | | 创业板指 | | 万得全A | | 968.04 | | 2059.12 | | 5179.88 | | -2.85 | -0.29% | +0.09% +1.79 | +9.55 | +0.18% | 从板块来看， 脑机接口概念股大涨 ，带动生物科技、制药、疫苗等板块走高，数字货币、工程机械、农药概念股表现活跃，而油气开采、 文化传媒、 谷子 经济等板块震荡调整。 | | | WIND热门概念指数 | | | | | WIND中国行业指 ...

脑机接口领域跑出一只牛股。6月16日，在美上市的中概股公司脑再生科技（RGC.US）股价 暴涨283%，盘中多次熔断，收报60美元，创下历史新高，总市值突破296亿美元，该股年内 累计涨超500倍。 脑再生科技是一家早期生物科学公司，于2014年在香港起步，主要运营及资产均在香港，目 前员工人数为12人，其专注于研究、开发和商业化中药，用于治疗神经认知障碍和退化，特 别是注意力缺陷多动障碍（ADHD）和自闭症谱系障碍（ASD）。其计划先在香港推出三种适 合轻、中、重度ADHD和ASD患者的液体化标准化中药配方，然后在其认为合适的情况下向其 他市场推广。 引爆公司股价的是当下备受瞩目的脑机接口技术 。此前5月9日，脑再生科技宣布其新一代神 经调控芯片通过FDA临床试验审批，将与全球顶尖医疗机构梅奥诊所合作，开展帕金森病治疗 研究。该神经调控芯片技术属于脑机接口领域的前沿方向，公司计划利用这一技术开展帕金森 病治疗研究，直击全球约1000万患者市场。 不过， 脑再生科技流通盘极小，日均成交量和换手率长期处于极低水平 。截至2024年10月 末，脑再生科技第一大股东与第二大股东合计持有88.80%公司股份。这意味着 ...

Group 1 - The core viewpoint of the article highlights a significant surge in Hong Kong's brain-computer interface concept stocks, with MicroPort NeuroTech (02172.HK) rising over 35% and Nanjing Panda Electronics (00553.HK) increasing by 36% [1]

A股开盘，沪指开跌0.02%，深证成指开涨0.14%，创业板指开涨0.2%，脑机接口概念股涨幅居前。 ...

A股脑机接口概念股开盘大涨，爱朋医疗、创新医疗竞价涨停，南京熊猫、三博脑科、诚益通、翔宇医 疗等多股高开。 ...